MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Enterprise Value came in at -$65.9 million in Q4 2025, up 36.4% YoY from -$48.3 million in Q4 2024, and down 344.25% on a QoQ basis from -$14.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Enterprise Value data on file, last reported at -$65.9 million in Q4 2025.
- Quarterly Enterprise Value rose 36.4% year-over-year to -$65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65.9 million (up 36.4% YoY) and the FY2025 annual result came in at -$65.9 million, up 36.4% from the prior year.
- Enterprise Value fell to -$65.9 million in Q4 2025, from -$14.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$14.8 million in Q3 2025 to a low of -$199.4 million in Q1 2021.
- A 5-year average of -$102.8 million and a median of -$108.7 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 94.14% — and 2025, when it soared 88.13%.
- Tracing MGTX's Enterprise Value over 5 years: stood at -$137.7 million in 2021, then climbed by 16.11% to -$115.5 million in 2022, then dropped by 13.1% to -$130.6 million in 2023, then climbed by 20.66% to -$103.7 million in 2024, then jumped by 36.4% to -$65.9 million in 2025.
- The last three Enterprise Value figures came in at -$65.9 million (Q4 2025), -$14.8 million (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | -65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.93 Mn |
| Sep 30, 2025 | -14.84 Mn |
| Jun 30, 2025 | -32.17 Mn |
| Mar 31, 2025 | -66.52 Mn |
| Dec 31, 2024 | -103.66 Mn |
| Sep 30, 2024 | -125.03 Mn |
| Jun 30, 2024 | -101.03 Mn |
| Mar 31, 2024 | -120.27 Mn |
| Dec 31, 2023 | -130.65 Mn |
| Sep 30, 2023 | -64.40 Mn |
| Jun 30, 2023 | -92.77 Mn |
| Mar 31, 2023 | -68.78 Mn |
| Dec 31, 2022 | -115.52 Mn |
| Sep 30, 2022 | -114.71 Mn |
| Jun 30, 2022 | -72.10 Mn |
| Mar 31, 2022 | -113.78 Mn |
| Dec 31, 2021 | -137.70 Mn |
| Sep 30, 2021 | -143.63 Mn |
| Jun 30, 2021 | -172.56 Mn |
| Mar 31, 2021 | -199.41 Mn |